Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose

NCT01421134 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

211

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder With Mixed Features

Interventions

DRUG: Lurasidone
DRUG: Placebo

Sponsor

Sumitomo Pharma America, Inc.